American Stroke Association-Bugher Foundation Center for Excellence in Brain Health for Hemorrhagic Stroke
Description: Intracerebral hemorrhage (ICH) is a medical emergency that triggers hospital admission. Among the 60%-70% who survive, nearly 2/3 will develop recurrent stroke or incident cognitive decline within 5 years. For Black and Hispanic ICH patients, the figure is even higher. This rapid functional decline arises from progression of the cerebral small vessel disease responsible for the ICH. Arresting this progression holds the promise of substantially improving brain health-span and quality of life for the >50,000 patients who survive ICH in the US alone every year. The American Stroke Association-Bugher Foundation Center for Excellence in Brain Health for Hemorrhagic Stroke is proposing ambitious, interrelated Clinical, Population and Basic Science projects and a training core that will catalyze innovations that preserve the brain health of patients who have had an ICH. By addressing the immediate opportunities of blood pressure (BP) control and physician generated intervention as well as the pressing need for novel therapeutics, our Center will yield sustained impact on brain health-span in ICH. Blood pressure (BP) control is strongly associated with brain health after ICH. Nonetheless, a majority of ICH patients do not achieve a healthy BP. Our clinical project will investigate the social determinants of BP control in ICH. Its results, combined with clinical, imaging and genetic data, will provide crucial information for design of interventions to improve BP control. Clinical tools exist that identify personalized modifiable risk factors for deterioration in brain health. In parallel, there is an extensive list of common genetic variants with impact on ICH and its comorbidities. Our population project will create a Brain Health Risk Assessment tool using the electronic health record. Using this tool, we will perform a clinical trial among physicians, testing for improved resource utilization to optimize brain health after ICH. We will also build and test polygenic risk scores for ICH and confirm their performance in diverse populations. Our basic project will investigate cortical superficial siderosis (CSS), a novel biomarker for recurrent hemorrhage in ICH. Combining innovative approaches to human neuropathology and laboratory models, we will seek to identify the biology linking CSS to clinical deterioration. Our goal is to generate targets for novel therapeutics that can ultimately be proven to preserve brain health after ICH.
Funder: American Heart Association
Amount: $679,100
Funding type: research
Funder scheme: Bugher Foundation Stroke Center
Start date: 2021-01-01
End date: 2024-12-31
Investigator: Jonathan Rosand (lead)
Institutions: Massachusetts General Hospital, Massachusetts General Hospital (Mass General)
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 9
Funder award ID: 812095
OpenAlex ID: G124926876
